Changes in plasma and platelet BDNF levels induced byS-citalopram in major depression
✍ Scribed by Montserrat Serra-Millàs; Irene López-Vílchez; Víctor Navarro; Ana-María Galán; Ginés Escolar; Rafael Penadés; Rosa Catalán; Lourdes Fañanás; Bárbara Arias; Cristóbal Gastó
- Publisher
- Springer
- Year
- 2011
- Tongue
- English
- Weight
- 175 KB
- Volume
- 216
- Category
- Article
- ISSN
- 0033-3158
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract The relationship between antidepressant effects and plasma levels of milnacipran was studied in 49 cases of major depression without psychotic features during 6 weeks of milnacipran treatment. The daily dose of milnacipran was 50 mg/day for the first week, and up to 100 mg/day thereafte
Recent studies have implicated brain-derived neurotrophic factor (BDNF) in the pathophysiology of depression and in the activities of antidepressant drugs. Serum BDNF levels are lower in depressed patients and increase in response to antidepressant medications; however, no studies have examined the
Changes in shape, and aggregation that accompanies platelet activation, are dependent on the assembly and reorganization of the cytoskeleton. To assess the changes in cytoskeleton induced by thrombin and PMA, suspensions of aspirin‐treated,^32^P‐prelabeled, washed pig platelets in Hepes buffer conta